A higher rate of embolization is considered a disadvantage of carotid stenting (CAS), when compared with carotid endarterectomy. Plaques in the aortic arch (AA) and the common carotid artery (CCA) may be additional sources of embolization to stented internal carotid plaques during CAS. In this study, we aimed to investigate the relationship between these plaques and intracerebral embolization.
Methods
We analyzed the occurrence and composition of plaques in the AA and CCA by computed tomography angiography (CTA) in 101 consecutive cases of CAS. Cases of peri-procedural embolization were detected on diffusion-weighted imaging as lesions demonstrating diffusion restriction. We applied the χ2 and Fisher’s exact tests, as well as logistic regression models.
Results
The occurrence of plaques in the AA and CCA was significantly related to the appearance of new diffusion-weighted imaging lesions (p = 0.013 and p = 0.004, respectively). Patients with soft plaques in the AA or CCA had a significantly higher risk of embolization than those without plaques (p = 0.012 and p = 0.006, respectively). In contrast, homogeneously calcified plaques did not pose significantly higher risks.
Conclusions
Soft plaques in the AA and CCA result in a substantial risk of embolization during CAS. Use of a CTA examination of the AA and the CCA in patients with carotid stenosis may help to select lower-risk patients for CAS.
ManteseVATimaranCHChiuD. The carotid revascularization endarterectomy versus stenting trial (CREST): Stenting versus carotid endarterectomy for carotid disease. Stroke2010; 41: S31–34.
2.
SchnaudigelSGröschelKPilgramSM. New brain lesions after carotid stenting versus carotid endarterectomy: A systematic review of the literature. Stroke2008; 39: 1911–1919.
3.
KimHJLeeHJYangJH. The influence of carotid artery catheterization technique on the incidence of thromboembolism during carotid artery stenting. Am J Neuroradiol2010; 31: 1732–1736.
4.
YoshimuraSToyodaKKuwashiroT. Ulcerated plaques in the aortic arch contribute to symptomatic multiple brain infarction. J Neurol Neurosurg Psychiatry2010; 81: 1306–1311.
5.
UchiyamaNMisakiKMohriM. Association between carotid plaque composition assessed by multidetector computed tomography and cerebral embolism after carotid stenting. Neuroradiology2012; 54: 487–493.
6.
WintermarkMJawadiSSRappJH. High-resolution CT imaging of carotid artery atherosclerotic plaques. Am J Neuroradiol2008; 29: 875–882.
7.
KoelemayMJWNederkoornPJReitsmaJB. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke2004; 35: 2306–2312.
8.
De WeertTTOuhlousMMeijeringE. In vivo characterization and quantification of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation. Arterioscler Thromb Vasc Biol2006; 26: 2366–2372.
9.
ChatzikonstantinouAKrissakRFlüchterS. CT angiography of the aorta is superior to transesophageal echocardiography for determining stroke subtypes in patients with cryptogenic ischemic stroke. Cerebrovasc Dis2012; 33: 322–328.
10.
SabaLCaddeoGSanfilippoR. CT and ultrasound in the study of ulcerated carotid plaque compared with surgical results: Potentialities and advantages of multidetector row CT angiography. Am J Neuroradiol2007; 28: 1061–1066.
11.
Du Mesnil de RochemontRSchneiderSYanB. Diffusion weighted MR imaging lesions after filter-protected stenting of high-grade symptomatic carotid artery stenosis. Am J Neuroradiol2006; 27: 1321–1325.
12.
KimSJRohHGJeonP. Cerebral ischemia detected with diffusion-weighted MR imaging after protected carotid artery stenting: Comparison of distal balloon and filter device. Korean J Radiol2007; 8: 276–285.
13.
LundCNesRBUgelstadTP. Cerebral emboli during left heart catheterization may cause acute brain injury. Eur Heart J2005; 26: 1269–1275.
14.
TureliHOUnganITuraliD. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: A diffusion-weighted MRI and neuron-specific enolase-based study. J Invasive Cardiol2013; 25: 519–524.
15.
North American Symptomatic Carotid Endarterectomy Trial (NASCET) Steering Committee. North American Symptomatic Carotid Endarterectomy Trial: Methods, patient characteristics and progress. Stroke1991; 22: 711–720.
KastrupANageleTGroschelK. Incidence of new brain lesions after carotid stenting with and without cerebral protection. Stroke2006; 37: 2312–2316.
18.
AsakuraFKawaguchiKSakaidaH. Diffusion weighted magnetic resonance imaging in carotid angioplasty and stenting with balloon embolic protection devices. Neuroradiology2006; 48: 100–112.
19.
RappJHWakilLSawhneyR. Subclinical embolization after carotid artery stenting: New lesions on diffusion-weighted magnetic resonance imaging occur postprocedure. J Vasc Surg2007; 45: 867–872.
20.
LacroixVHammerFAstarciP. Ischemic cerebral lesions after carotid surgery and carotid stenting. Eur J Vasc Endovasc Surg2007; 33: 430–435.
21.
SchlüterMTüblerTSteffensJC. Focal ischemia of the brain after neuroprotected carotid artery stenting. J Am Coll Cardiol2003; 42: 1007–1013.
22.
YadavJS. Stenting and angioplasty with protection in patients at high risk for endarterectomy: The SAPPHIRE study. Circulation2002; 106: 2986.
23.
YamadaKYoshimuraSKawasakiM. Embolic complications after carotid artery stenting or carotid endarterectomy are associated with tissue characteristics of carotid plaques evaluated by magnetic resonance imaging. Atherosclerosis2011; 215: 399–404.
24.
BiasiGMFroioADietrichEB. Carotid plaque echolucency increases the risk of stroke in carotid stenting: The imaging in carotid angioplasty and risk of stroke (ICAROS) study. Circulation2004; 110: 756–762.
25.
TegosTJSabetaiMMNicolaidesAN. Correlates of embolic events detected by means of transcranial Doppler in patients with carotid atheroma. J Vasc Surg2001; 33: 131–138.
26.
StojanovDIlicMBosnjakovicP. New ischemic brain lesions on diffusion-weighted MRI after carotid artery stenting with filter protection: Frequency and relationship with plaque morphology. Am J Neuroradiol2012; 33: 708–714.
27.
ChenZIchetovkinMKurtzM. Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability. Lipids Health Dis2010; 9: 61.
28.
SchonholczCJUflackerRParodiJC. Is there evidence that cerebral protection is beneficial? Clinical data. J Cardiovasc Surg2006; 47: 137–141.
29.
Pinero P, Gonzalez A, Mayol A, et al. Silent ischemia after neuroprotected percutaneous carotid stenting: A diffusion-weighted MRI study. American Journal of Neuroradiology, 2006; 27: 1338–1345.
30.
CremonesiAManettiRSetacciF. Protected carotid stenting: Clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke2003; 34: 1936–1941.
31.
EckertBZeumerH. Editorial comment: Carotid artery stenting with or without protection devices? Strong opinions, poor evidence!. Stroke2003; 34: 1941–1943.
32.
KnippSCMatatkoNWilhelmH. Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion weighted magnetic resonance imaging. Eur J Cardio-Thoracic Surg2004; 25: 791–800.
33.
GensickeHVan der WorpHBNederkoornPJ. Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk. J Am Coll Cardiol2015; 65: 521–529.
34.
WillinskyRATaylorSMTerBruggeK. Neurologic complications of cerebral angiography: Prospective analysis of 2899 procedures and review of the literature. Radiology2003; 227: 522–5228.
35.
SzikraPVörösESztrihaL. Forces exerted on the plaques during in vitro measurements by various carotid stent delivery systems and embolic protection devices. Hungar Radiol2008; 82: 202–205.
